SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Engelborghs S) "

Sökning: WFRF:(Engelborghs S)

  • Resultat 1-10 av 59
  • [1]23456Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • de Rojas, I., et al. (författare)
  • Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
  • 2021
  • Ingår i: Nature Communications. - : Springer Nature. - 2041-1723 .- 2041-1723. ; 12:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Genetic discoveries of Alzheimer’s disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer’s disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer’s disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer’s disease.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Bos, I., et al. (författare)
  • Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
  • 2019
  • Ingår i: Alzheimers & Dementia. - : Elsevier. - 1552-5260 .- 1552-5279. ; 15:5, s. 644-654
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: We investigated relations between amyloid-beta (A beta) status, apolipoprotein E (APOE) e4, and cognition, with cerebrospinal fluid markers of neurogranin (Ng), neurofilament light (NFL), YKL-40, and total tau (T-tau). Methods: We included 770 individuals with normal cognition, mild cognitive impairment, and Alzheimer's disease (AD)-type dementia from the EMIF-AD Multimodal Biomarker Discovery study. We tested the association of Ng, NFL, YKL-40, and T-tau with A beta status (Ab beta- vs. A beta+), clinical diagnosis APOE epsilon 4 carriership, baseline cognition, and change in cognition. Results: Ng and T-tau distinguished between A beta+ from A beta- individuals in each clinical group, whereas NFL and YKL-40 were associated with A beta+ in nondemented individuals only. APOE epsilon 4 carriership did not influence NFL, Ng, and YKL-40 in A beta+ individuals. NFL was the best predictor of cognitive decline in A beta+ individuals across the cognitive spectrum. Discussion: Axonal degeneration, synaptic dysfunction, astroglial activation, and altered tau metabolism are involved already in preclinical AD. NFL may be a useful prognostic marker. (C) 2019 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
  •  
8.
  • Mattsson, Niklas, et al. (författare)
  • Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
  • 2018
  • Ingår i: Alzheimer's and Dementia. - : Wiley. - 1552-5260 .- 1552-5279. ; 14:7, s. 913-924
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Apolipoprotein E (APOE) ε4 is the major genetic risk factor for Alzheimer's disease (AD), but its prevalence is unclear because earlier studies did not require biomarker evidence of amyloid β (Aβ) pathology. Methods: We included 3451 Aβ+ subjects (853 AD-type dementia, 1810 mild cognitive impairment, and 788 cognitively normal). Generalized estimating equation models were used to assess APOE ε4 prevalence in relation to age, sex, education, and geographical location. Results: The APOE ε4 prevalence was 66% in AD-type dementia, 64% in mild cognitive impairment, and 51% in cognitively normal, and it decreased with advancing age in Aβ+ cognitively normal and Aβ+ mild cognitive impairment (P <.05) but not in Aβ+ AD dementia (P =.66). The prevalence was highest in Northern Europe but did not vary by sex or education. Discussion: The APOE ε4 prevalence in AD was higher than that in previous studies, which did not require presence of Aβ pathology. Furthermore, our results highlight disease heterogeneity related to age and geographical location.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 59
  • [1]23456Nästa
Typ av publikation
tidskriftsartikel (55)
konferensbidrag (2)
forskningsöversikt (2)
Typ av innehåll
refereegranskat (55)
övrigt vetenskapligt (4)
Författare/redaktör
Engelborghs, S (58)
Lleo, A (35)
Vandenberghe, R (31)
Sleegers, K. (30)
Tsolaki, M (28)
Engelborghs, Sebasti ... (26)
visa fler...
Scheltens, P (25)
Van Broeckhoven, C (25)
Zetterberg, H. (22)
Zetterberg, Henrik, ... (22)
Frisoni, Giovanni B. (22)
Visser, PJ (21)
Blennow, Kaj, 1958 (20)
Blennow, K (20)
Lovestone, S (20)
Popp, J. (20)
Scheltens, Philip (19)
Teunissen, Charlotte ... (18)
Molinuevo, JL (18)
Lleó, Alberto (18)
de Mendonça, A (18)
Visser, Pieter Jelle (18)
Martinez-Lage, P (18)
Vos, Stephanie J. B. (18)
Bos, I (17)
Tsolaki, Magda (16)
Wallin, A (16)
Vandenberghe, Rik (16)
Bertram, L (16)
Streffer, J. (16)
De Deyn, PP (15)
Frisoni, GB (15)
Graff, C (15)
Frolich, L (15)
Clarimon, J (15)
Dobricic, V. (15)
Barkhof, F (14)
Popp, Julius (14)
Gelpi, E (13)
Molinuevo, José Luis (13)
Sanchez-Valle, R (13)
Legido-Quigley, C (13)
Johannsen, Peter (13)
Pastor, P (12)
Soininen, H (12)
Lovestone, Simon (12)
Teunissen, CE (12)
Blin, O (12)
Frölich, Lutz (12)
van der Zee, J (12)
visa färre...
Lärosäte
Göteborgs universitet (36)
Karolinska Institutet (33)
Örebro universitet (11)
Lunds universitet (4)
Uppsala universitet (2)
Stockholms universitet (1)
visa fler...
Linköpings universitet (1)
Jönköping University (1)
visa färre...
Språk
Engelska (59)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (39)
Naturvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy